Ignite Creation Date:
2024-05-06 @ 4:14 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04922957
Status:
TERMINATED
Last Update Posted:
2024-03-13
First Post:
2021-06-09
Brief Title:
A Phase 2b Multi-Center Randomized Double-Blind Placebo-Controlled Study Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome ARDS
Sponsor:
Enlivex Therapeutics Ltd
Organization:
Enlivex Therapeutics Ltd
Organization Data
Organization:
Enlivex Therapeutics Ltd
Class:
INDUSTRY
Study ID:
ENX-CL-03-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Enlivex Therapeutics Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None